Fresenius Medical Care AG & Co. KGaA (FMEN) Stock Statistics & Valuation Metrics
Total Valuation
Fresenius Medical Care AG & Co. KGaA has a market cap or net worth of MXN 232.58B. The enterprise value is MXN 21.16B.
- Market Cap
- MXN 232.58B
- Enterprise Value
- MXN 21.16B
Share Statistics
Fresenius Medical Care AG & Co. KGaA has 268,564,640 shares outstanding. The number of shares has decreased by -2.65% in one year.
- Shares Outstanding
- 268,564,640
- Owned by Insiders
- ―
- Owned by Institutions
- 28.55%
Financial Efficiency
Fresenius Medical Care AG & Co. KGaA’s return on equity (ROE) is 0.07 and return on invested capital (ROIC) is 5.34%.
- Return on Equity (ROE)
- 0.07
- Return on Assets (ROA)
- 0.03
- Return on Invested Capital (ROIC)
- 5.34%
- Return on Capital Employed (ROCE)
- 0.07
- Revenue Per Employee
- 183.05K
- Profits Per Employee
- 9,120.922
- Employee Count
- 107,226
- Asset Turnover
- 0.63
- Inventory Turnover
- 6.82
Valuation Ratios
The current PE Ratio of Fresenius Medical Care AG & Co. KGaA is 14.12. Fresenius Medical Care AG & Co. KGaA’s PEG ratio is 0.66.
- PE Ratio
- 14.12
- PS Ratio
- 0.58
- PB Ratio
- 0.87
- Price to FCF
- 6.26
- Price to Operating Cash Flow
- 3.85
- PEG Ratio
- 0.66
Income Statement
In the last 12 months, Fresenius Medical Care AG & Co. KGaA had revenue of 19.63B and earned 978.00M in profits. Earnings per share was 3.36.
- Revenue
- 19.63B
- Gross Profit
- 5.03B
- Operating Income
- 1.83B
- Pretax Income
- 1.51B
- Net Income
- 978.00M
- EBITDA
- 3.34B
- Earnings Per Share (EPS)
- 3.36
Cash Flow
In the last 12 months, operating cash flow was 2.89B and capital expenditures -1.09B, giving a free cash flow of 1.79B billion.
- Operating Cash Flow
- 2.89B
- Free Cash Flow
- 1.79B
- Free Cash Flow per Share
- 6.83
Dividends & Yields
Fresenius Medical Care AG & Co. KGaA pays an annual dividend of ―, resulting in a dividend yield of 3.84%
- Dividend Per Share
- ―
- Dividend Yield
- 3.84%
- Payout Ratio
- N/A
- Free Cash Flow Yield
- 15.97%
- Earnings Yield
- 7.41%
Stock Price Statistics
- Beta
- 0.01
- 52-Week Price Change
- -8.66%
- 50-Day Moving Average
- 791.30
- 200-Day Moving Average
- 783.44
- Relative Strength Index (RSI)
- 99.95
- Average Volume (3m)
- ―
Important Dates
Fresenius Medical Care AG & Co. KGaA upcoming earnings date is Feb 23, 2027, TBA (Not Confirmed).
- Last Earnings Date
- Nov 03, 2026
- Next Earnings Date
- Feb 23, 2027
- Ex-Dividend Date
- ―
Financial Position
Fresenius Medical Care AG & Co. KGaA as a current ratio of 1.26, with Debt / Equity ratio of 81.11%
- Current Ratio
- 1.26
- Quick Ratio
- 0.92
- Debt to Market Cap
- 0.62
- Net Debt to EBITDA
- 2.76
- Interest Coverage Ratio
- 4.74
Taxes
In the past 12 months, Fresenius Medical Care AG & Co. KGaA has paid 321.00M in taxes.
- Income Tax
- 321.00M
- Effective Tax Rate
- 0.21
Enterprise Valuation
Fresenius Medical Care AG & Co. KGaA EV to EBITDA ratio is 5.96, with an EV/FCF ratio of 11.71.
- EV to Sales
- 1.08
- EV to EBITDA
- 5.96
- EV to Free Cash Flow
- 11.71
- EV to Operating Cash Flow
- 7.28
Balance Sheet
Fresenius Medical Care AG & Co. KGaA has MXN 1.48B in cash and marketable securities with MXN 10.89B in debt, giving a net cash position of -MXN 9.40B billion.
- Cash & Marketable Securities
- MXN 1.48B
- Total Debt
- MXN 10.89B
- Net Cash
- -MXN 9.40B
- Net Cash Per Share
- -MXN 35.01
- Tangible Book Value Per Share
- -MXN 5.77
Margins
Gross margin is 26.46%, with operating margin of 10.64%, and net profit margin of 4.22%.
- Gross Margin
- 26.46%
- Operating Margin
- 10.64%
- Pretax Margin
- 7.20%
- Net Profit Margin
- 4.22%
- EBITDA Margin
- 18.12%
- EBIT Margin
- 10.30%
Analyst Forecast
The average price target for Fresenius Medical Care AG & Co. KGaA is MXN 758.71, which is 11.43% higher than the current price. The consensus rating is Moderate Sell
- Price Target
- MXN 758.71
- Price Target Upside
- 7.70% Downside
- Analyst Consensus
- Moderate Sell
- Analyst Count
- 10
- Revenue Growth Forecast
- -6.36%
- EPS Growth Forecast
- 15.38%
Scores
- Smart Score
- 1
- AI Score
- ―

